Los Angeles Capital Management’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $237K | Buy |
68,615
+3,275
| +5% | +$11.3K | ﹤0.01% | 1129 |
|
|
2025
Q1 | $171K | Buy |
65,340
+12,570
| +24% | +$32.9K | ﹤0.01% | 1043 |
|
|
2024
Q4 | $217K | Buy |
52,770
+20,880
| +65% | +$86K | ﹤0.01% | 1035 |
|
|
2024
Q3 | $226K | Sell |
31,890
-74,279
| -70% | -$526K | ﹤0.01% | 1092 |
|
|
2024
Q2 | $692K | Buy |
106,169
+92,230
| +662% | +$601K | ﹤0.01% | 769 |
|
|
2024
Q1 | $116K | Buy |
13,939
+2,850
| +26% | +$23.7K | ﹤0.01% | 1118 |
|
|
2023
Q4 | $122K | Hold |
11,089
| – | – | ﹤0.01% | 1111 |
|
|
2023
Q3 | $93.3K | Buy |
11,089
+175
| +2% | +$1.47K | ﹤0.01% | 1093 |
|
|
2023
Q2 | $137K | Buy |
+10,914
| New | +$137K | ﹤0.01% | 1134 |
|
|
2022
Q4 | – | Sell |
-10,604
| Closed | -$237K | – | 1266 |
|
|
2022
Q3 | $237K | Buy |
+10,604
| New | +$237K | ﹤0.01% | 1143 |
|